IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 1 filers reported holding IMMUNE DESIGN CORP in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $248,000 | +350.9% | 42,400 | 0.0% | 0.00% | +200.0% |
| Q4 2018 | $55,000 | -92.8% | 42,400 | -80.8% | 0.00% | -85.7% |
| Q3 2018 | $763,000 | +106.2% | 221,192 | +172.1% | 0.01% | +75.0% |
| Q2 2018 | $370,000 | -34.0% | 81,292 | -52.2% | 0.00% | -33.3% |
| Q1 2018 | $561,000 | +24.9% | 170,000 | +47.8% | 0.01% | +20.0% |
| Q4 2017 | $449,000 | -62.9% | 115,000 | -1.5% | 0.01% | -64.3% |
| Q3 2017 | $1,209,000 | +7.9% | 116,800 | +1.6% | 0.01% | 0.0% |
| Q2 2017 | $1,121,000 | +43.4% | 115,000 | 0.0% | 0.01% | +55.6% |
| Q1 2017 | $782,000 | +23.5% | 115,000 | 0.0% | 0.01% | +12.5% |
| Q4 2016 | $633,000 | -27.4% | 115,000 | 0.0% | 0.01% | -38.5% |
| Q3 2016 | $872,000 | – | 115,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 1,962,720 | $16,016,000 | 6.52% |
| Abingworth LLP | 197,300 | $1,610,000 | 1.69% |
| NEXTHERA CAPITAL LP | 85,138 | $695,000 | 0.60% |
| Cormorant Asset Management, LP | 432,990 | $3,533,000 | 0.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 153,000 | $1,248,000 | 0.32% |
| TFS CAPITAL LLC | 102,685 | $838,000 | 0.15% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,227,595 | $10,017,000 | 0.10% |
| Eventide Asset Management | 180,000 | $1,469,000 | 0.09% |
| Focused Wealth Management, Inc | 15,868 | $129,000 | 0.06% |
| Spark Investment Management LLC | 77,500 | $632,000 | 0.06% |